Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Conclusions: Recent study results are changing management of MCL. Although these data have complicated the picture of regimen selection, increasingly effective and tolerable therapy and additional anticipated data point to a brighter future for patients with MCL. PMID: 32079411 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32079411?dopt=Abstract

Source: The Annals of Pharmacotherapy - February 19, 2020 Category: Drugs & Pharmacology Authors: Buege MJ, Kumar A, Dixon BN, Tang LA, Pak T, Orozco J, Peterson TJ, Maples KT Tags: Ann Pharmacother Source Type: research